Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global point of care coagulation testing products market 360° synopsis, 2018 – 2032
2.2 Regional trends
2.3 Test type trends
2.4 Product type trends
Chapter 3 Point of Care Coagulation Testing Products Industry Insights
3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
3.5.1 Growth drivers
3.5.1.1 Rising prevalence of chronic blood disorders
3.5.1.2 Growing government initiatives to curb blood-related diseases
3.5.1.3 Increasing adoption of point of care testing products
3.5.1.4 Technological advancements
3.5.2 Industry pitfalls & challenges
3.5.2.1 Stringent regulatory framework
3.5.2.2 High cost of product development
3.6 Growth potential analysis
3.6.1 By test type
3.6.2 By product type
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Thermo Fisher Scientific Inc
4.1.3 Medtronic plc
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022
Chapter 5 Point of Care Coagulation Testing Products Market Estimates and Forecast, By Test Type (Revenue and Volume)
5.1 Key trends, by test type
5.2 Prothrombin time testing products
5.3 Activated clotting time (ACT/APTT) testing products
5.4 Others
Chapter 6 Point of Care Coagulation Testing Products Market Estimates and Forecast, By Product Type (Revenue)
6.1 Key trends, by product type
6.2 Instruments
6.3 Consumables
Chapter 7 Point of Care Coagulation Testing Products Market Estimates and Forecast, By Region (Revenue and Volume)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Switzerland
7.3.7 The Netherlands
7.3.8 Denmark
7.3.9 Poland
7.3.10 Sweden
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 New Zealand
7.4.7 Thailand
7.4.8 Vietnam
7.4.9 Indonesia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Turkey
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Helena Laboratories
8.3 Thermo Fisher Scientific Inc
8.4 Alere Inc.
8.5 Medtronic plc
8.6 Sysmex Corporation
8.7 Diagnostica Stago Sas
8.8 Nihon Kohden Corporation
8.9 Micropoint Biosciences
8.10 F. Hoffmann-La Roche Ltd
